ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
29 hedge funds and large institutions have $2.89M invested in Argos Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
48% less capital invested
Capital invested by funds: $5.57M → $2.89M (-$2.67M)
Holders
29
Holding in Top 10
1
Calls
$956K
Puts
$36K
Top Buyers
| 1 | +$120K | |
| 2 | +$27K | |
| 3 | +$22K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7K |
Top Sellers
| 1 | -$40K | |
| 2 | -$30K | |
| 3 | -$19K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$17K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
-$16K |